期刊文献+

支气管哮喘合并焦虑小鼠大脑中神经肽S的含量及其与炎性因子的关系 被引量:4

The levels of neuropeptide S in the brain of asthmatic mice with anxiety and the relationship with the inflammatory mediators
原文传递
导出
摘要 目的 探究支气管哮喘(哮喘)合并焦虑小鼠模型大脑中神经肽S含量的变化,并在体外实验研究炎性因子对神经元分泌神经肽S的影响.方法 将40只BALB/C小鼠按随机数字表法随机分为对照组、哮喘组、焦虑组以及哮喘合并焦虑组,实时荧光定量PCR法检测各组动物模型脑组织中神经肽S mRNA相对表达量;体外原代培养大鼠大脑皮层神经元细胞,分为磷酸盐缓冲液(PBS)对照组、IL-1β组、IL-6组和肿瘤坏死因子(TNF)-α组,用炎性因子刺激神经元后,QRT-PCR法检测各组神经肽S mRNA表达水平,ELISA法检各组细胞培养液中神经肽S的含量.结果 各组动物模型大脑中神经肽S mRNA的相对表达量,焦虑组(0.88 ±0.05)和哮喘合并焦虑组(0.79 ±0.03)明显低于对照组(1.01 ±0.05)和哮喘组(0.96±0.06),并且哮喘合并焦虑组明显低于其他3组,差异均有统计学意义(均P <0.05).IL-6组和TNF-α组神经肽S mRNA相对表达量分别为0.88±0.07和0.86±0.07,均明显低于PBS对照组(1.00±0.06)和IL-1β组(0.94 ±0.08),差异均有统计学意义(均P<0.05);IL-1β组神经肽S mRNA相对表达量与PBS对照组相比,差异无统计学意义(t=-1.81,P=0.079).IL-6组和TNF-α组培养液中神经肽S含量分别为(45.4±1.2) ng/L和(46.0±1.0) ng/L,均明显低于PBS对照组的(50.6±1.8) ng/L和IL-1β组的(49.5±1.0) ng/L,差异均有统计学意义(均P<0.05);IL-1β组培养液中神经肽S含量与PBS对照组相比,差异无统计学意义(t=-1.89.P=0.067).结论 哮喘血清中升高的IL-6、TNF-α可抑制神经元细胞分泌神经肽S,具有抗焦虑作用的神经肽S含量下降,易导致焦虑的发生,这可能是哮喘与焦虑共病的机制之一. Objective To investigate the levels of neuropeptide S in the brain of asthmatic mice with anxiety and the effects of inflammatory mediatores on changes of neuropeptide S in in vitro experiments.Methods According to the random number table method,40 BALB/C mice were randomly divided into 4 groups:the control group,the asthma group,the anxiety group and the asthma and anxiety group.The relative expressions of neuropeptidc S mRNA in the brain tissue of each group were detected by quantitative real-time polymerase chain reaction (QRT-PCR).Rat cortex neurons obtained by primary culture were divided into 4 groups:the PBS control group,the interleukin-1 beta group,the interleukin-6 group and the tumor necrosis factor-alpha group.After stimulation with inflammatory cytokines the mRNA expressions of neuropeptide S were measured by QRT-PCR and neuropeptide S levels in the cell culture supernatants were measured by emzyme linked immunosorbent assay (ELISA).Results The relative expressions of neuropeptide S mRNA were decreased in the anxiety group(0.87 ± 0.05) and the asthma and anxiety group (0.79 ± 0.03) compared with the control group (1.00 ± 0.05) and the asthma group (0.96 ± 0.06),most notably in the asthma and anxiety group (all P 〈 0.05).Compared to the PBS control group [(1.00 ±0.06),(50.6 ± 1.8) ng/L] and the interleukin-1 beta group [(0.94 ± 0.08),(49.5 ± 1.0) ng/L],the levels of neuropeptide S mRNA and neuropeptide S were decreased in the interleukin-6 group [(0.88 ± 0.07),(45.4 ± 1.2) ng/L] and the tumor necrosis factor-alpha group [(0.86 ± 0.07),(46.0 ± 1.0) ng/L] (all P 〈 0.05).There were no significant differences between the interleukin-1 beta group and the PBS control group(all P 〉 0.05).Conclusions Up-regulated interleukin-6 and tumor necrosis factor-alpha in asthma can inhibit the secretion of neuropeptide S in neuronal cells.The decline of brain neuropeptide S,which has anti-anxiety effect,may lead to the occurrence of anxiety,which may be a potential mechanism of comorbidity of asthma and anxiety.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2016年第10期779-783,共5页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 河南省教育厅科学技术研究重点项目(13A320697) 河南省科学技术厅科技攻关项目(132300410273) 河南省卫生科技创新型人才工程(豫卫科2010-52)
关键词 焦虑 哮喘 神经肽类 炎性因子 Anxiety Asthma Neuropeptides Inflammatory factors
  • 相关文献

参考文献17

二级参考文献118

  • 1孙鲲,林科雄,吴奎,王长征.CD_4^+ CD_(25)^+T淋巴细胞对支气管哮喘小鼠气道炎症的影响及作用机制[J].中华结核和呼吸杂志,2006,29(2):109-112. 被引量:15
  • 2韩宏志,李波,孔宁,李善玉,史杰萍,宁宇,方芳,姚燕.GPRA基因rs324396位点单核苷酸多态性与儿童支气管哮喘的相关性研究[J].疾病控制杂志,2006,10(4):321-323. 被引量:2
  • 3张晓岩,林江涛.支气管哮喘的流行病学及发病危险因素[J].中华结核和呼吸杂志,2007,30(7):538-541. 被引量:48
  • 4Pommer AM, Pouwer F, Denollet J, et al. Managing co-morbid depression and anxiety in primary care patients with asthma and/or chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. Trials, 2012, 13: 6.
  • 5Teesson M, Mitchell PB, Deady M, et al. Affective and anxiety disorders and their relationship with chronic physical conditions in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry, 2011,45 : 939-946.
  • 6Vashadze SH. Anxiety, depression, panic disorder and bronchial asthma. Georgian Med News, 2011, 11: 63-67.
  • 7Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life : depressive disorders, anxiety disorders, or both?. Chest, 2006, 130: 1039-1047.
  • 8Isensee B, Wittchen HU, Stein MB, et al. Smoking increases the risk of panic : findings from a prospective community study. Arch Gen Psychiatry, 2003, 60: 692-700.
  • 9James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Bussehon Health Study: the effects of asthma and cigarette smoking. Am J Respir Cfit Care Med, 2005, 171 : 109-114.
  • 10Vieira AA, Santoro IL, Dracoulakis S, et al. Anxiety and depression in asthma patients: impact on asthma control. J Bras Pneumol, 2011, 37 : 13-18.

共引文献55

同被引文献43

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部